| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Artal Group S A | 11.26M (16.15%) | 0.00 Increased by 0.00% | Jun 30, 24 |
| 2 | FMR Inc | 10.20M (14.62%) | 308.81K Increased by +3.03% | Sep 30, 24 |
| 3 | T. Rowe Price Associates, Inc. | 8.65M (12.41%) | 465.98K Increased by +5.38% | Sep 30, 24 |
| 4 | Samsara BioCapital, LLC | 6.79M (9.73%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 5 | BlackRock Inc | 5.66M (8.12%) | 658.53K Increased by +11.63% | Jun 30, 24 |
| 6 | Redmile Group, LLC | 5.24M (7.51%) | -214.25K Decreased by -4.09% | Sep 30, 24 |
| 7 | State Street Corporation | 4.17M (5.98%) | 2.01M Increased by +48.21% | Mar 31, 24 |
| 8 | Vanguard Group Inc | 4.03M (5.79%) | 198.10K Increased by +4.91% | Sep 30, 24 |
| 9 | Polar Capital Holdings PLC | 2.94M (4.22%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 10 | State Street Corp | 2.77M (3.98%) | -35.41K Decreased by -1.28% | Sep 30, 24 |
| 11 | Eventide Asset Management, LLC | 2.41M (3.45%) | -665.27K Decreased by -27.61% | Sep 30, 24 |
| 12 | Hood River Capital Management LLC | 2.35M (3.37%) | 1.52M Increased by +64.56% | Sep 30, 24 |
| 13 | Bellevue Group AG | 2.16M (3.10%) | -4.00K Decreased by -0.19% | Sep 30, 24 |
| 14 | Geode Capital Management, LLC | 1.54M (2.21%) | 120.49K Increased by +7.81% | Sep 30, 24 |
| 15 | Goldman Sachs Group Inc | 1.40M (2.01%) | 60.12K Increased by +4.30% | Sep 30, 24 |
| 16 | Adage Capital Partners Gp LLC | 1.30M (1.86%) | 1.30M Increased by +100.00% | Dec 31, 23 |
| 17 | Candriam Luxembourg S.C.A. | 1.16M (1.66%) | 411.09K Increased by +35.58% | Sep 30, 24 |
| 18 | MPM Oncology Impact Management LP | 1.03M (1.47%) | 1.03M Increased by +100.00% | Jun 30, 24 |
| 19 | Millennium Management LLC | 925.58K (1.33%) | 568.51K Increased by +61.42% | Jun 30, 24 |
| 20 | ClearBridge Advisors, LLC | 924.39K (1.33%) | 177.29K Increased by +19.18% | Sep 30, 24 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | T. Rowe Price New Horizons | 3.92M (5.62%) | -12.35K Decreased by -0.32% | Sep 30, 24 |
| 2 | US Small-Cap Growth II Equity Comp | 3.92M (5.62%) | -13.94K Decreased by -0.36% | Sep 30, 24 |
| 3 | Fidelity Growth Compy Commingled Pl S | 3.66M (5.25%) | 66.86K Increased by +1.83% | Sep 30, 24 |
| 4 | Fidelity Growth Compy Commingled Pl O | 3.59M (5.15%) | 36.80K Increased by +1.02% | Aug 31, 24 |
| 5 | Polar Capital Biotech S Inc | 2.99M (4.29%) | 239.04K Increased by +8.00% | Oct 31, 24 |
| 6 | Fidelity Growth Company Fund | 2.75M (3.94%) | 28.23K Increased by +1.03% | Sep 30, 24 |
| 7 | Fidelity® Select Biotechnology | 2.49M (3.57%) | 428.93K Increased by +17.25% | Nov 30, 23 |
| 8 | Vanguard Total Stock Mkt Idx Inv | 2.42M (3.47%) | 125.53K Increased by +5.19% | Oct 31, 24 |
| 9 | Fidelity® Growth Company | 2.19M (3.13%) | 66.00K Increased by +3.02% | Nov 30, 23 |
| 10 | BB Biotech AG Ord | 2.13M (3.06%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 11 | iShares Russell 2000 ETF | 1.92M (2.76%) | -4.02K Decreased by -0.21% | Nov 27, 24 |
| 12 | T. Rowe Price Health Sciences | 1.72M (2.47%) | 140.59K Increased by +8.17% | Sep 30, 24 |
| 13 | Eventide Healthcare & Life Sciences I | 1.69M (2.42%) | 622.61K Increased by +36.91% | Jun 30, 24 |
| 14 | Fidelity Advisor® Biotechnology I | 1.67M (2.39%) | 0.00 Increased by 0.00% | Nov 30, 23 |
| 15 | Fidelity Select Biotechnology | 1.63M (2.34%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 16 | Eventide Gilead N | 1.38M (1.98%) | 934.53K Increased by +67.61% | Jun 30, 24 |
| 17 | Hood River Small-Cap Growth Instl | 1.28M (1.83%) | 855.28K Increased by +67.06% | Sep 30, 24 |
| 18 | SPDR® S&P Biotech ETF | 1.27M (1.82%) | -38.52K Decreased by -3.04% | Nov 27, 24 |
| 19 | Vanguard Institutional Extnd Mkt Idx Tr | 1.06M (1.52%) | 97.95K Increased by +9.24% | Oct 31, 24 |
| 20 | T. Rowe Price New Horizons Tr-Z | 894.56K (1.28%) | 93.69K Increased by +10.47% | Sep 30, 24 |